Targeted and armed oncolytic adenovirus via chemoselective modification

Partha Banerjee, Edison S. Zuniga, Iwao Ojima, Isaac S. Carrico

Research output: Contribution to journalArticle

Abstract

Oncolytic adenoviruses (Ads) are an emerging alternative therapy for cancer; however, clinical trial have not yet demonstrated sufficient efficacy. When oncolytic Ads are used in combination with taxoids a synergistic increase in both cytotoxicity and viral replication is observed. In order to generate a next generation oncolytic adenovirus, virion were physically conjugated to a highly potent taxoid, SB-T-1214, and a folate targeting motif. Conjugation was enabled via the metabolic incorporation of non-canonical monosaccharides (O-GlcNAz) and amino acids (homopropargylglycine), which served as sites for chemoselective modification.

Original languageEnglish (US)
Pages (from-to)4985-4988
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number17
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Taxoids
Adenoviridae
Monosaccharides
Cytotoxicity
Folic Acid
Complementary Therapies
Amino Acids
Virion
Clinical Trials
Neoplasms
homopropargylglycine
SB T-1214

Keywords

  • Adenovirus
  • Chemoselective
  • Click
  • Gene delivery
  • Non-canonical
  • Oncolytic
  • Paclitaxel
  • Staudinger
  • Taxoid
  • Unnatural

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Targeted and armed oncolytic adenovirus via chemoselective modification. / Banerjee, Partha; Zuniga, Edison S.; Ojima, Iwao; Carrico, Isaac S.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 21, No. 17, 01.09.2011, p. 4985-4988.

Research output: Contribution to journalArticle

Banerjee, Partha ; Zuniga, Edison S. ; Ojima, Iwao ; Carrico, Isaac S. / Targeted and armed oncolytic adenovirus via chemoselective modification. In: Bioorganic and Medicinal Chemistry Letters. 2011 ; Vol. 21, No. 17. pp. 4985-4988.
@article{8dc1e65ca9434d5fb440ee88a2767dd9,
title = "Targeted and armed oncolytic adenovirus via chemoselective modification",
abstract = "Oncolytic adenoviruses (Ads) are an emerging alternative therapy for cancer; however, clinical trial have not yet demonstrated sufficient efficacy. When oncolytic Ads are used in combination with taxoids a synergistic increase in both cytotoxicity and viral replication is observed. In order to generate a next generation oncolytic adenovirus, virion were physically conjugated to a highly potent taxoid, SB-T-1214, and a folate targeting motif. Conjugation was enabled via the metabolic incorporation of non-canonical monosaccharides (O-GlcNAz) and amino acids (homopropargylglycine), which served as sites for chemoselective modification.",
keywords = "Adenovirus, Chemoselective, Click, Gene delivery, Non-canonical, Oncolytic, Paclitaxel, Staudinger, Taxoid, Unnatural",
author = "Partha Banerjee and Zuniga, {Edison S.} and Iwao Ojima and Carrico, {Isaac S.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.bmcl.2011.05.039",
language = "English (US)",
volume = "21",
pages = "4985--4988",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "17",

}

TY - JOUR

T1 - Targeted and armed oncolytic adenovirus via chemoselective modification

AU - Banerjee, Partha

AU - Zuniga, Edison S.

AU - Ojima, Iwao

AU - Carrico, Isaac S.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Oncolytic adenoviruses (Ads) are an emerging alternative therapy for cancer; however, clinical trial have not yet demonstrated sufficient efficacy. When oncolytic Ads are used in combination with taxoids a synergistic increase in both cytotoxicity and viral replication is observed. In order to generate a next generation oncolytic adenovirus, virion were physically conjugated to a highly potent taxoid, SB-T-1214, and a folate targeting motif. Conjugation was enabled via the metabolic incorporation of non-canonical monosaccharides (O-GlcNAz) and amino acids (homopropargylglycine), which served as sites for chemoselective modification.

AB - Oncolytic adenoviruses (Ads) are an emerging alternative therapy for cancer; however, clinical trial have not yet demonstrated sufficient efficacy. When oncolytic Ads are used in combination with taxoids a synergistic increase in both cytotoxicity and viral replication is observed. In order to generate a next generation oncolytic adenovirus, virion were physically conjugated to a highly potent taxoid, SB-T-1214, and a folate targeting motif. Conjugation was enabled via the metabolic incorporation of non-canonical monosaccharides (O-GlcNAz) and amino acids (homopropargylglycine), which served as sites for chemoselective modification.

KW - Adenovirus

KW - Chemoselective

KW - Click

KW - Gene delivery

KW - Non-canonical

KW - Oncolytic

KW - Paclitaxel

KW - Staudinger

KW - Taxoid

KW - Unnatural

UR - http://www.scopus.com/inward/record.url?scp=80051785643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051785643&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2011.05.039

DO - 10.1016/j.bmcl.2011.05.039

M3 - Article

VL - 21

SP - 4985

EP - 4988

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 17

ER -